| Adrienne A Truxillo, NP | |
|
1514 Jefferson Hwy, New Orleans, LA 70121-2429 | |
| (504) 842-3900 | |
| Not Available |
| Full Name | Adrienne A Truxillo |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 1514 Jefferson Hwy, New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003152554 | NPI | - | NPPES |
| 09982845 | Medicaid | MS | |
| 2320971 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0200X | Nurse Practitioner - Pediatrics | AP06813 (Louisiana) | Primary |
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
Drinking alcohol may reduce the severity of rheumatoid arthritis according to new research published today. It is the first time that this effect has been shown in humans. The study also finds that alcohol consumption reduces the risk of developing the disease, confirming the results of previous studies.
Researchers at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) and several collaborating institutions have linked mutations in specific genes to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children. The discovery, reported July in the journal Nature, provides doctors with potential biomarkers for guiding and individualizing treatment and reveals prospective therapeutic opportunities for countering this devastating malignancy.
Around one in four Montrealers take some kind of anti-depressant, and according to new research, the drugs are passing into the waterways and affecting fish. The findings are internationally significant as the city's sewage treatment system is similar to that in use in other major cities, and moreover, it is reputed to be the third largest treatment system in the world.
Researchers have found the first proof that a chemical in the brain called glutamate is linked to suicidal behavior, offering new hope for efforts to prevent people from taking their own lives.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adrienne A Truxillo, NP 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-3900 | Adrienne A Truxillo, NP 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-3900 |
News Archive
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
Drinking alcohol may reduce the severity of rheumatoid arthritis according to new research published today. It is the first time that this effect has been shown in humans. The study also finds that alcohol consumption reduces the risk of developing the disease, confirming the results of previous studies.
Researchers at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) and several collaborating institutions have linked mutations in specific genes to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children. The discovery, reported July in the journal Nature, provides doctors with potential biomarkers for guiding and individualizing treatment and reveals prospective therapeutic opportunities for countering this devastating malignancy.
Around one in four Montrealers take some kind of anti-depressant, and according to new research, the drugs are passing into the waterways and affecting fish. The findings are internationally significant as the city's sewage treatment system is similar to that in use in other major cities, and moreover, it is reputed to be the third largest treatment system in the world.
Researchers have found the first proof that a chemical in the brain called glutamate is linked to suicidal behavior, offering new hope for efforts to prevent people from taking their own lives.
› Verified 5 days ago
Tammy Ann Francipane, RNC CNNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Elaine Alleman, NP, RN, MSN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 335 Audubon Blvd, New Orleans, LA 70125 Phone: 985-264-8037 Fax: 504-865-0371 | |
Dr. Demetrius James Porche, RN, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1900 Gravier St, New Orleans, LA 70112 Phone: 504-568-4106 | |
Emily P Landry, APRN, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2700 Napoleon Ave, New Orleans, LA 70115 Phone: 504-894-2050 | |
Ms. Leontine Maxine Trought, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2700 S Broad St, New Orleans, LA 70125 Phone: 504-383-8559 Fax: 504-371-5162 | |
Camille Yount, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3525 Prytania St Ste 501, New Orleans, LA 70115 Phone: 504-895-3676 |